2018 SUMMIT REGISTRATION PARTNERING PRESENTING SPEAKERS AGENDA 2017 SUMMIT ABOUT US HOTEL

About the Summit

CTIC Capital is dedicated to creating valuable connections through the annual summit for US companies that are interested in raising capital and developing business relationships in China.
Get ready to pitch  
We will bring you Chinese investors (150) who are actively searching for investing and business collaborating opportunities in the US. New for 2018, we will select 6-8 companies out of hundreds of applications to present and be evaluated by investors.
 
Get ready to be inspired
Impressive line up of investors from US and China to share challenges and opportunities in areas such as: Precision Medicine, Early Drug Development, Medical Devices, Cross Border M&A, Fund Raising and more.
 
Get ready to connect
One-on-One partnering system will assist you in submitting inquiries for One-on-One meetings. The system will open by December 15th, 2017.
 

Speakers

Randy W. Schekman (Keynote)
Nobel laureate, the 2013 Nobel Prize in Physiology or Medicine
Professor of Molecular and Cell Biology, University of California, Berkeley
 
Kevin Chen
Managing Partner, Biotrack Capital
 
Michael Chan
Sr. VP, Hong Kong Exchanges and Clearing Ltd. ("HKEX")
 
Yingying Chen
Executive Director, GF Investments (Hong Kong) Company Limited
 
Ted Driscoll
Managing Director, DigitalDX Ventures
 
Samantha Du
Chairwoman and CEO, Zai Lab
 
Doug Fisher
Partner, InterWest Partners
 
David Flores
Co-Founder, President & CEO, BioCentury
 
Julie Papanek Grant
Partner, Canaan
 
Hongjie Hu
Investment Director, Temasek
 
Patrick Heron
Managing General Partner, Frazier Healthcare Partners
 
James Huang
Managing Partner, KPCB China
 
Alexis Ji
Partner, lllumina Ventures
 
Nisa Leung
Managing Partner, Qiming Ventures Partners
 
Yanhong Lin
Founder and Managing Partner, CTIC Capital
 
Derek Liu
Partner-Elect, Mergers & Acquisitions, WSRG
 
Hongbo Lu
Partner, Lilly Asia Ventures
 
Xiaobo Lu
Partner, Sequoia Capital China
 
Hai Mi
Founding Managing Partner, Panacea Venture
 
Amy Schulman
Entrepreneur Partner, Polaris Partners & Partner, LSP Fund
 
Christopher Shen
Managing Partner, Qiming Venture Partners
 
Alvin Syh
CEO, Buchang Asset Management;
General Manager, Anrich Capital Asia
 
Khoon Jin Tan
Partner, Corporate, WSGR
 
Barry Taylor
Partner, Corporate, WSRG
 
Karen Wong
Partner, Intellectual Property, WSGR
 
Jerry Xiao
CEO, Hermed Capital
 
Grace Xu
SVP for Biomedicine Business, SanPower; Chairwoman, Denderon Corporation
 
Jiang Zhang
Managing Director, Ping An Venture
 
Lily Zhang
Partner, CDH Venture
 
Frank Zhang
CEO, GenScript Biotech Corporation; Chairman, Nanjing Legend
 
Richard Zhao
Chief Investment Officer & SVP, Medical Technology Division, Fosun Pharma
       
 

Agenda

MORNING SESSION
  08:00-09:20AM Registration / Networking / Breakfast
  09:20-09:25AM Welcoming Remarks
    Yanhong Lin, Managing Partner, CTIC Capital
  09:25-10:10AM Keynote Speech: Prospects for Use of Exosomes in Cancer Diagnosis and Treatment
    Randy W. Schekman, Nobel laureate, the 2013 Nobel Prize in Physiology or Medicine
  10:10-10:55AM Panel Discussion I: Chinese Investment & M&A Opportunities – Where Is the Money?
    Alexis Ji, Parnter, Illumina Ventures (Panel Lead)
James Huang, Managing Partner, KPCB China
Hongbo Lu, Partner, Lilly Asia Ventures
Xiaobo Lu, Partner, Sequoia Capital China
Jerry Xiao, CEO, Hermed Capital
  10:55-11:40AM Panel Discussion II: Successful Equity Investments and M&A & Why Others Failed
    Karen Wong, Partner, Intellectual Property, WSGR (Panel Lead)
Hai Mi, Founding Managing Partner, Panacea Venture
Christopher Shen, Managing Partner, Qiming Venture Parners
Alvin Syh, CEO, Buchang Asset Management; General Manager, Anrich Capital Asia
Grace Xu, SVP for Biomedicine Business, SanPower; Chairwoman, Denderon Corporation
  11:40-12:55PM Lunch / Special Session Hosted by WSGR: Capitalizing On Cross-Border Healthcare Investments, M&A, and Public Offerings
    Michael Chan, SVP, Hong Kong Exchanges and Clearing Ltd.("HKEX")
Derek Liu, Partner-Elect, Mergers & Acquisitions, WSGR
Khoon Jin Tan, Partner, Corporate, WSGR
Barry Taylor, Partner, Corporate, WSGR
Karen Wong, Partner, Intellectual Property, WSGR
AFTERNOON SESSION
  12:55-01:55PM Company Presentations: Epic Sciences, Tessa Therapeutics, Sera Prognostics
    Hongjie Hu, Investment Director, Temasek
Yingying Chen, Executive Director, GF Investments (Hong Kong) Company Limited
Jiang Zhang, Managing Director, Ping An Venture
  01:55-02:40PM Panel Discussion III: US Healthcare Investment Trend – Where Would the US VCs Invest in Healthcare?
    Doug Fisher, Partner, InterWest Partners (Panel Lead)
Ted Driscoll, Managing Director, DigitalDx Ventures
Julie Papanek Grant, Partner, Canaan
Patrick Heron, Managing General Partner, Frazier Healthcare Partners
Amy Schulman, Entrepreneur Partner, Polaris Partners
  02:40-02:55PM Break
  02:55-03:55PM Company Presentations: Quantapore, BioClin Therapeutics, Connect Biopharma
    Kevin Chen, Founding Partner, Biotrack Capital
Lily Zhang, Partner, CDH Venture
David Flores, Co-Founder, President & CEO, BioCentury
  03:55-04:40PM Panel Discussion IV: Cross-Border Business Development, Joint Venture, and Licensing Opportunities
    Samantha Du, Chairman and CEO, Zai Lab
Nisa Leung, Managing Partner, Qiming Ventures Partners
Frank Zhang, CEO, GenScript; Chairman, Nanjing Legend
Richard Zhao, GM Strategy and Investment & SVP, Medical Device, Fosun Pharma
  04:40-05:00PM Closing
  05:00-07:00PM Networking
 

Overview of 2017 CTIC Capital
Healthcare Investment Summit

 

Feedback from Our 2017 Summit Attendees

CTIC CAPITAL

     
 
CTIC Capital is a Silicon Valley based boutique private equity consulting firm focusing on healthcare, Internet technology, and renewable energy. Leveraging our Trans-Pacific network and local expertise, CTIC Capital helps enterprises in the US and China in funding, M&A, and strategic partnership development. Our goal is to be the trusted advisor to companies for US-China cross-border investment and partnership opportunities.
 
     
 

CONTACT US

 
ning.feng@cticcapital.com
yanhong.lin@cticcapital.com